Insulin aspart, recombinant Subcutaneous and Xenleta (Lefamulin Tablets)
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Xenleta (Lefamulin Tablets) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: lefamulin
Brand name: Xenleta
Synonyms: Xenleta (Lefamulin Injection), Xenleta, Xenleta (oral/injection)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Xeomin
- Insulin aspart, recombinant Subcutaneous-Xerava
- Insulin aspart, recombinant Subcutaneous-Xerese
- Insulin aspart, recombinant Subcutaneous-Xerese Cream
- Insulin aspart, recombinant Subcutaneous-Xermelo
- Insulin aspart, recombinant Subcutaneous-Xgeva
- Xenleta (Lefamulin Tablets)-Insulin degludec
- Xenleta (Lefamulin Tablets)-Insulin Degludec (U-100) Prefilled Pens
- Xenleta (Lefamulin Tablets)-Insulin Degludec (U-100) Vials
- Xenleta (Lefamulin Tablets)-Insulin Degludec (U-200) Prefilled Pens
- Xenleta (Lefamulin Tablets)-Insulin degludec and liraglutide
- Xenleta (Lefamulin Tablets)-Insulin degludec and liraglutide Subcutaneous